RHYTHM PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Shares Outstanding (Cover Page) of 68.85 million shares as of 2026-08-01, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-04
- 2026-08-01: Entity Common Stock, Shares Outstanding 68.85M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 68.53M shares.
- 2026-02-24: Entity Common Stock, Shares Outstanding 68.29M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 66.74M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-01 | 68.85M shares 10-Q · filed 2026-08-04 |
| 2026-05-01 | 68.53M shares 10-Q · filed 2026-05-05 |
| 2026-02-24 | 68.29M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 66.74M shares 10-Q · filed 2025-11-04 |
| 2025-08-01 | 66.42M shares 10-Q · filed 2025-08-05 |
| 2025-04-30 | 63.62M shares 10-Q · filed 2025-05-07 |
| 2025-02-24 | 63.22M shares 10-K · filed 2025-02-28 |
| 2024-11-03 | 61.46M shares 10-Q · filed 2024-11-06 |
| 2024-08-01 | 61.13M shares 10-Q/A · filed 2024-08-14 |
| 2024-05-01 | 60.97M shares 10-Q · filed 2024-05-07 |
| 2024-02-23 | 60.14M shares 10-K · filed 2024-02-29 |
| 2023-11-01 | 59.10M shares 10-Q · filed 2023-11-08 |
| 2023-07-26 | 56.90M shares 10-Q · filed 2023-08-01 |
| 2023-04-24 | 56.85M shares 10-Q · filed 2023-05-02 |
| 2023-02-22 | 56.75M shares 10-K · filed 2023-03-01 |
| 2022-11-02 | 56.35M shares 10-Q · filed 2022-11-08 |
| 2022-07-28 | 50.72M shares 10-Q · filed 2022-08-03 |
| 2022-04-27 | 50.39M shares 10-Q · filed 2022-05-03 |
| 2022-02-22 | 50.33M shares 10-K · filed 2022-03-01 |
| 2021-10-26 | 50.27M shares 10-Q · filed 2021-11-02 |
| 2021-07-26 | 50.23M shares 10-Q · filed 2021-08-03 |
| 2021-04-23 | 50.21M shares 10-Q · filed 2021-05-03 |
| 2021-02-19 | 50.18M shares 10-K · filed 2021-03-01 |
| 2020-10-23 | 44.20M shares 10-Q · filed 2020-11-02 |
| 2020-07-24 | 44.12M shares 10-Q · filed 2020-08-03 |
| 2020-04-24 | 44.09M shares 10-Q · filed 2020-05-04 |
| 2020-02-28 | 44.06M shares 10-K · filed 2020-03-02 |
| 2019-10-31 | 43.93M shares 10-Q · filed 2019-11-01 |
| 2019-07-25 | 34.52M shares 10-Q · filed 2019-07-29 |
| 2019-04-30 | 34.43M shares 10-Q · filed 2019-05-03 |
| 2019-03-01 | 34.43M shares 10-K · filed 2019-03-08 |
| 2018-11-08 | 34.41M shares 10-Q · filed 2018-11-09 |
| 2018-08-03 | 34.18M shares 10-Q · filed 2018-08-08 |
| 2018-05-11 | 27.53M shares 10-Q · filed 2018-05-14 |
| 2018-03-09 | 27.28M shares 10-K · filed 2018-03-12 |
| 2017-11-10 | 27.28M shares 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |